D.C. Henderson

543 total citations
25 papers, 411 citations indexed

About

D.C. Henderson is a scholar working on Immunology and Allergy, Physiology and Immunology. According to data from OpenAlex, D.C. Henderson has authored 25 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology and Allergy, 6 papers in Physiology and 5 papers in Immunology. Recurrent topics in D.C. Henderson's work include Allergic Rhinitis and Sensitization (7 papers), Food Allergy and Anaphylaxis Research (6 papers) and Asthma and respiratory diseases (5 papers). D.C. Henderson is often cited by papers focused on Allergic Rhinitis and Sensitization (7 papers), Food Allergy and Anaphylaxis Research (6 papers) and Asthma and respiratory diseases (5 papers). D.C. Henderson collaborates with scholars based in United Kingdom, Australia and United States. D.C. Henderson's co-authors include P G Riches, Alan Steel, Peter Kelleher, D.M. Moran, J R Hobbs, Julie Sheldon, Anton Pozniak, Mark Nelson, Sally A. Clark and Brant R. Ward and has published in prestigious journals such as Acta Psychiatrica Scandinavica, Journal of the Neurological Sciences and Developmental Medicine & Child Neurology.

In The Last Decade

D.C. Henderson

25 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.C. Henderson United Kingdom 11 169 117 116 71 70 25 411
Steven Polyak United States 12 147 0.9× 102 0.9× 83 0.7× 142 2.0× 119 1.7× 21 519
B. J. Dezube United States 9 114 0.7× 53 0.5× 103 0.9× 213 3.0× 48 0.7× 20 420
M Doucette United States 6 247 1.5× 60 0.5× 73 0.6× 193 2.7× 36 0.5× 8 567
Najwa El‐Nachef United States 12 116 0.7× 88 0.8× 160 1.4× 45 0.6× 31 0.4× 31 362
Shunji Matsuda Japan 11 83 0.5× 25 0.2× 84 0.7× 31 0.4× 120 1.7× 28 346
Sanna Kilpinen Finland 7 80 0.5× 25 0.2× 59 0.5× 48 0.7× 105 1.5× 10 314
Mohammad Taghi Rezayati Iran 14 109 0.6× 181 1.5× 29 0.3× 35 0.5× 213 3.0× 33 491
A J Wakefield United Kingdom 9 192 1.1× 116 1.0× 58 0.5× 62 0.9× 67 1.0× 17 400
Thomas Wendland Switzerland 14 204 1.2× 39 0.3× 109 0.9× 40 0.6× 187 2.7× 18 657
H Rasokat Germany 11 137 0.8× 41 0.4× 68 0.6× 68 1.0× 84 1.2× 43 470

Countries citing papers authored by D.C. Henderson

Since Specialization
Citations

This map shows the geographic impact of D.C. Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.C. Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.C. Henderson more than expected).

Fields of papers citing papers by D.C. Henderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.C. Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.C. Henderson. The network helps show where D.C. Henderson may publish in the future.

Co-authorship network of co-authors of D.C. Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of D.C. Henderson. A scholar is included among the top collaborators of D.C. Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.C. Henderson. D.C. Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Gold, Ralf, Ali Jawad, David H. Miller, et al.. (2007). Expert opinion: Guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies. Journal of Neuroimmunology. 187(1-2). 156–158. 41 indexed citations
4.
Clark, Sally A., Sarah Martin, Anton Pozniak, et al.. (2007). Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease. Clinical & Experimental Immunology. 150(2). 238–244. 76 indexed citations
5.
Henderson, D.C., R Clifford, & Donn Young. (2001). Mercury-reactive lymphocytes in peripheral blood are not a marker for dental amalgam associated disease. Journal of Dentistry. 29(7). 469–474. 8 indexed citations
6.
Youle, M, D.C. Henderson, Deenan Pillay, et al.. (1999). Chronic erosive herpes simplex virus infection of the penis, a possible immune reconstitution disease. HIV Medicine. 1(1). 10–18. 72 indexed citations
7.
Henderson, D.C., et al.. (1999). Carbamazepine hypersensitivity and the use of lymphocyte proliferation responses. Developmental Medicine & Child Neurology. 41(4). 267–269. 9 indexed citations
8.
Henderson, D.C., et al.. (1999). Carbamazepine hypersensitivity and the use of lymphocyte proliferation responses. Developmental Medicine & Child Neurology. 41(4). 267–269. 2 indexed citations
9.
Guiloff, R J, et al.. (1996). Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNFα). Journal of the Neurological Sciences. 138(1-2). 134–144. 14 indexed citations
10.
Henderson, D.C., et al.. (1996). Inflammatory and immunological markers in preterm infants: correlation with disease. Clinical & Experimental Immunology. 105(3). 551–555. 28 indexed citations
11.
Riches, P G, et al.. (1994). Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomy. British Journal of Urology. 74(1). 15–22. 30 indexed citations
12.
Henderson, D.C., et al.. (1993). Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neck. European Journal of Cancer Part B Oral Oncology. 29(1). 29–34. 13 indexed citations
13.
Henderson, D.C., et al.. (1991). Stimulatory effects of FK156 in a panel of tests designed to detect changes in immune function. International Journal of Immunopharmacology. 13(2-3). 117–124. 2 indexed citations
14.
Henderson, D.C., et al.. (1989). Immunological evaluation of paroxetine. Acta Psychiatrica Scandinavica. 80(S350). 40–40. 1 indexed citations
15.
Henderson, D.C., et al.. (1988). Immunological studies on paroxetine, a novel anti-depressant drug. International Journal of Immunopharmacology. 10(4). 361–367. 12 indexed citations
16.
Wheeler, A.W., et al.. (1987). Immunogenicity in Guinea Pigs and Tolerance in Grass Pollen-Sensitive Volunteers of Enteric-Coated Grass Pollen Allergens. International Archives of Allergy and Immunology. 83(4). 354–358. 10 indexed citations
17.
Henderson, D.C. & D.M. Moran. (1986). Antibody Responses of Mice to Intragastric and Parenterally Administered Aeroallergens. International Archives of Allergy and Immunology. 79(1). 66–71. 3 indexed citations
18.
Henderson, D.C., D.M. Moran, & A.W. Wheeler. (1985). Differential suppressive influence of intranasal application of rye grass pollen extract on IgE antibody production in the mouse.. PubMed. 59(2). 343–50. 3 indexed citations
19.
Wheeler, A.W., et al.. (1985). Suppression of Murine IgE Responses with Amino Acid Polymer/Allergen Conjugates. International Archives of Allergy and Immunology. 76(4). 361–368. 8 indexed citations
20.
Moran, D.M., R. Standring, & D.C. Henderson. (1982). Antibody Response Profiles to Components of Rye Grass Pollen Extract in Various Strains of Mice. International Archives of Allergy and Immunology. 69(2). 120–126. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven Polyak Breakdown of academic impact, for papers by B. J. Dezube Breakdown of academic impact, for papers by M Doucette Breakdown of academic impact, for papers by Najwa El‐Nachef Breakdown of academic impact, for papers by Shunji Matsuda Breakdown of academic impact, for papers by Sanna Kilpinen Breakdown of academic impact, for papers by Mohammad Taghi Rezayati Breakdown of academic impact, for papers by A J Wakefield Breakdown of academic impact, for papers by Thomas Wendland Breakdown of academic impact, for papers by H Rasokat
Rankless by CCL
2026